How Medication Treats Addiction

What does medication-assisted treatment mean?

Medication-assisted treatment, or MAT, is the use of an FDA-approved medication together with counseling and social support to treat a substance use disorder. Many clinicians now prefer the narrower term medication for opioid use disorder, or MOUD, because for opioids the medicine is not a mere assist — it is the core of the treatment, an evidence-based standard of care 1Ref 1National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.That medications for opioid use disorder are an evidence-based standard of care, that treating OUD with methadone or buprenorphine is not substituting one addiction for another because the medications reduce cravings and withdrawal without producing a high at therapeutic doses, and that substance use disorders and other mental illnesses frequently co-occur and should be treated together..

MOUD is medication for opioid use disorder — the newer name for the opioid form of MAT.

The word "assisted" is a leftover from an older way of thinking, when medication was treated as a crutch you leaned on until the real work of willpower kicked in. That framing is backwards for opioid addiction. The medication changes the underlying brain chemistry that drives craving, and the counseling supports the life a person is trying to rebuild around it. Neither piece is optional decoration on the other.

MAT is not one drug. It is a category covering different medications for different substances, each working in a different way. Some occupy the same receptors the drug acted on and calm them. Some block those receptors entirely. Some make drinking physically unpleasant. What they share is that they are prescribed, monitored, and — this matters — none of them produces the high that the addictive drug did when taken as directed.

Which medications treat opioid addiction?

Three medications are FDA-approved for opioid use disorder: methadone, buprenorphine, and naltrexone 2Ref 2Substance Abuse and Mental Health Services Administration (2021).TIP 63: Medications for Opioid Use Disorder — Full Document.That the three FDA-approved medications for opioid use disorder are methadone, buprenorphine, and naltrexone, and that medication for OUD is delivered alongside the counseling and social services that support recovery.. They divide into two mechanisms. Methadone and buprenorphine are agonists — they act on the same opioid receptors heroin or fentanyl acted on, but slowly and steadily, so they relieve withdrawal and craving without the surge that produces a high. Naltrexone is the opposite: a blocker that sits on the receptor and lets nothing bind to it.

Methadone is a full agonist, dispensed through federally regulated opioid treatment programs. Its steady, long-acting effect holds withdrawal off for a full day. Buprenorphine (the ingredient in Suboxone) is a partial agonist with a ceiling: past a certain point, more medication does not produce more effect, which is part of why it is safer in overdose and can be prescribed from a regular doctor's office. Naltrexone, given as a monthly injection (Vivitrol), blocks opioids entirely, so it suits someone who has already gotten through withdrawal and wants nothing on the receptor at all.

All three are real treatment — the choice between them is a clinical fit, not a ranking of who is trying harder.

The guideline of record recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, and it says medication should not be arbitrarily limited to a fixed number of days 4Ref 4American Society of Addiction Medicine (2020).The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update.That the guideline recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, that medication should not be withheld because of ongoing use of other substances, and that medication should not be arbitrarily time-limited.. How each medicine is chosen and started is its own subject, covered in the spokes on how buprenorphine works and how methadone works.

Which medications treat alcohol addiction?

Three medications are FDA-approved for alcohol use disorder: naltrexone, acamprosate, and disulfiram 3Ref 3National Institute on Alcohol Abuse and Alcoholism (2024).Recommend Evidence-Based Treatment: Know the Options.That three FDA-approved medications treat alcohol use disorder — naltrexone, acamprosate, and disulfiram — that they are non-addictive and can be used with or without counseling, and that they are substantially underused.. They are not addictive, they can be used with or without counseling, and — despite decades of evidence — they remain substantially underused, prescribed to only a small fraction of the people who could benefit 3Ref 3National Institute on Alcohol Abuse and Alcoholism (2024).Recommend Evidence-Based Treatment: Know the Options.That three FDA-approved medications treat alcohol use disorder — naltrexone, acamprosate, and disulfiram — that they are non-addictive and can be used with or without counseling, and that they are substantially underused.. Many people never learn these options exist.

Each works differently. Naltrexone blunts the reward from drinking, so a drink brings less of the effect a person was chasing. Acamprosate works on a brain that is trying to stabilize after long, heavy drinking, easing the restlessness and unease of early abstinence. Disulfiram takes a different route entirely: it makes the body react badly to alcohol, so drinking brings on a fast, unpleasant physical reaction — a deterrent rather than a craving-reducer.

These are the alcohol use disorder medications a primary-care doctor or an addiction specialist can prescribe. The underprescribing is the striking part: a person with high blood pressure would be offered medication without hesitation, but a person with alcohol use disorder is often offered only a referral to a meeting. Both the medication and the mutual-help group are legitimate; the medication simply gets left out of the conversation far more often than the evidence warrants. Each of these medicines has its own spoke covering how it is taken and who it fits.

Is medication just trading one addiction for another?

No. This is the trading one addiction myth, and it rests on confusing two different things: physical dependence and addiction. A person stabilized on methadone or buprenorphine may be physically dependent on the medication — their body would notice if it stopped — but they are not addicted to it 1Ref 1National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.That medications for opioid use disorder are an evidence-based standard of care, that treating OUD with methadone or buprenorphine is not substituting one addiction for another because the medications reduce cravings and withdrawal without producing a high at therapeutic doses, and that substance use disorders and other mental illnesses frequently co-occur and should be treated together.. At a therapeutic dose the medication does not produce a high, and it does not drive the compulsive, harmful, out-of-control use that defines addiction.

Physical dependence is not addiction. Insulin, blood-pressure pills, and antidepressants all create dependence; none is an addiction.

The physical dependence vs addiction distinction matters because the myth has real costs. When families, drug courts, or even some treatment programs treat medication as "still using," they pressure people off the one thing keeping them alive. The federal position is direct: treating opioid use disorder with methadone or buprenorphine is not substituting one addiction for another — the medications reduce cravings and withdrawal without producing a high at the doses used in treatment 1Ref 1National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.That medications for opioid use disorder are an evidence-based standard of care, that treating OUD with methadone or buprenorphine is not substituting one addiction for another because the medications reduce cravings and withdrawal without producing a high at therapeutic doses, and that substance use disorders and other mental illnesses frequently co-occur and should be treated together.. The NIDA MOUD is not substitution point is not a matter of opinion; it is what the receptor pharmacology shows.

The guideline reinforces this from another angle: medication should not be withheld from someone because they are still using other substances 4Ref 4American Society of Addiction Medicine (2020).The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update.That the guideline recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, that medication should not be withheld because of ongoing use of other substances, and that medication should not be arbitrarily time-limited.. Recovery is rarely a clean straight line, and cutting off the protective medication at the first stumble removes protection exactly when the risk is highest.

What does the evidence say about medication versus other treatment?

For opioid use disorder, medication does something no other treatment has been shown to do: it lowers the risk of dying. A study of 40,885 adults compared six treatment pathways and found that only buprenorphine or methadone was linked to reduced overdose and serious opioid-related emergencies at three and twelve months 5Ref 5Wakeman SE, Larochelle MR, Ameli O, et al. (2020).Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.That among six treatment pathways in 40,885 adults with opioid use disorder, only buprenorphine or methadone was associated with reduced overdose and serious opioid-related acute care use at 3 and 12 months, while inpatient/residential treatment and intensive behavioral interventions were not.. Inpatient and residential treatment, and intensive behavioral programs, were not 5Ref 5Wakeman SE, Larochelle MR, Ameli O, et al. (2020).Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.That among six treatment pathways in 40,885 adults with opioid use disorder, only buprenorphine or methadone was associated with reduced overdose and serious opioid-related acute care use at 3 and 12 months, while inpatient/residential treatment and intensive behavioral interventions were not..

That finding surprises people, because residential rehab is what the culture pictures when it hears "treatment." But a 28-day stay that ends without medication leaves a person with lowered tolerance and unchanged cravings — a combination that raises overdose risk in the weeks after discharge.

A landmark meta-analysis found all-cause mortality of roughly 11 versus 36 deaths per 1,000 person-years — in treatment versus out of it — for people on methadone 6Ref 6Sordo L, Barrio G, Bravo MJ, et al. (2017).Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.That retention on methadone or buprenorphine is associated with substantially lower all-cause and overdose mortality than being out of treatment, with all-cause mortality of roughly 11.3 versus 36.1 per 1,000 person-years in versus out of methadone treatment..

Retention is the mechanism. Staying on methadone or buprenorphine is associated with substantially lower all-cause and overdose mortality than being out of treatment 6Ref 6Sordo L, Barrio G, Bravo MJ, et al. (2017).Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.That retention on methadone or buprenorphine is associated with substantially lower all-cause and overdose mortality than being out of treatment, with all-cause mortality of roughly 11.3 versus 36.1 per 1,000 person-years in versus out of methadone treatment.. The protection comes from being on the medication, not from having once completed a program. This is why clinicians describe opioid use disorder more like a chronic condition managed over time than an acute illness cured in a month. It also reframes what "success" means: staying engaged and alive is the outcome that matters most, and how long rehab should actually be looks different once dying is the thing you are trying to prevent.

Why is there no medication for stimulant or every other addiction?

There is no FDA-approved medication for stimulant use disorder — cocaine or methamphetamine addiction — the way there is for opioids and alcohol. The biology is different: stimulants act on dopamine circuits in a way that has not yielded a medication that reliably reduces use. That gap does not mean stimulant addiction is untreatable. It means the most effective treatment is behavioral rather than pharmacological.

For stimulant addiction medication, the honest answer is that the strongest evidence points to contingency management — a structured program that gives tangible rewards for verified abstinence. It is among the most effective interventions for stimulant use disorder, yet it faces regulatory and reimbursement barriers that keep it far less available than the evidence warrants 7Ref 7National Academies of Sciences, Engineering, and Medicine (2023).Contingency Management for the Treatment of Substance Use Disorders: Enhancing Access, Quality, and Program Integrity for an Evidence-Based Intervention.That contingency management is a strongly evidence-based behavioral treatment and among the most effective interventions for stimulant use disorder — for which no medication is FDA-approved — while facing regulatory and reimbursement barriers to access.. Contingency management for stimulants is the closest thing to a specific, proven treatment, and it is not a medication at all.

A missing pill does not mean a missing path. The most evidence-backed treatment for stimulants simply happens to be behavioral.

One medication category is worth separating out to avoid confusion: overdose-reversal drugs. Naloxone and nalmefene reverse an opioid overdose in the moment 8Ref 8National Institute on Drug Abuse (2024).Overdose Reversal Medications.That FDA-approved overdose-reversal medications — naloxone and nalmefene — exist and are used to reverse an opioid overdose in the moment, distinct from ongoing treatment of the addiction.. They are life-saving, but they are rescue medications, not treatment — they do nothing for the underlying addiction once the emergency passes. Keeping naloxone on hand and being in treatment are two different, complementary things.

How does medication fit with the rest of treatment?

Medication is one part of a plan, not the whole of it. The federal consensus reference describes MOUD as medication plus the counseling and social services that support recovery — housing, employment, treatment for other conditions 2Ref 2Substance Abuse and Mental Health Services Administration (2021).TIP 63: Medications for Opioid Use Disorder — Full Document.That the three FDA-approved medications for opioid use disorder are methadone, buprenorphine, and naltrexone, and that medication for OUD is delivered alongside the counseling and social services that support recovery.. The medication makes the daily grind of craving survivable; the surrounding support helps a person build the life that makes staying in recovery worth it.

Where treatment happens varies. Methadone is dispensed through federally regulated opioid treatment programs. Buprenorphine can be prescribed from an ordinary medical office, which has widened access considerably. The alcohol medications can come from primary care. There is no single door, and the right one depends on the substance, the severity, and what a person can actually get to.

Co-occurring conditions are the rule, not the exception. Substance use disorders and other mental illnesses frequently occur together, and treatment works better when both are addressed at the same time rather than one after the other 1Ref 1National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.That medications for opioid use disorder are an evidence-based standard of care, that treating OUD with methadone or buprenorphine is not substituting one addiction for another because the medications reduce cravings and withdrawal without producing a high at therapeutic doses, and that substance use disorders and other mental illnesses frequently co-occur and should be treated together.. A person medicated for opioid use disorder but left untreated for depression is being half-treated.

Cost and coverage are a real barrier, and how insurance coverage for rehab works is its own subject worth understanding before you start. Being on MAT is a legitimate, recognized form of recovery — the question of whether being on MAT is really recovery has a clear answer in the affirmative. What matters is that the treatment fits the person, and that it is not cut short by a myth.